Studies of CSF samples from patients with AD are consistent with these observations and suggest that Aβ allosterically potentiates the ACh-hydrolysing capacity of BuChE [16], particularly in the presence of high levels of apolipoprotein E [14–16,38]. Here, APOE is linked to Alzheimer disease.